Operation CBDeceit involves complaints against 6 companies
The Federal Trade Commission (FTC) announced on Thursday that it launched the first law enforcement crackdown on “deceptive” claims being made about CBD products. The new action involves complaints against six companies.
As part of “Operation CBDeceit,” FTC is mandating that the firms and personnel associated with them stop making a “wide range of scientifically unsupported claims” about their products’ ability to treat medical conditions. Some of the companies will also have to pay monetary judgements.
“The six settlements announced today send a clear message to the burgeoning CBD industry: Don’t make spurious health claims that are unsupported by medical science,” Andrew Smith, Director of FTC’s Bureau of Consumer Protection, said in a press release. “Otherwise, don’t be surprised if you hear from the FTC.”
To Read The Rest Of This Article On Marijuana Moment, Click Here